Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LJ2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,223
Award facts
- Contract value 100% obligated
- $30,222.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $30.2K to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) on January 15, 2026, with completion targeted for January 16, 2026. This competitively awarded, non-set-aside contract was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and utilized firm fixed-price pricing. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a ceiling value of $999.99M through December 2031 and serves as the primary vehicle for supplying pharmaceutical products and medical commodities to military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal agencies, particularly the Defense Health Agency and military treatment facilities. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications across multiple therapeutic domains, including specialty pharmaceuticals, vaccines, and medical devices. The DESCOVY delivery order supports the Defense Logistics Agency's mission to supply medications to military healthcare systems, ensuring the availability of this antiretroviral medication for authorized federal medical beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9LJ2?
SPE2DR26F9LJ2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LJ2 worth?
The government has obligated $30,223 on SPE2DR26F9LJ2.
Is contract SPE2DR26F9LJ2 an order under another contract?
Yes. SPE2DR26F9LJ2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LJ2 competed?
The extent of competition for SPE2DR26F9LJ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award